Troutman Pepper advised Century Therapeutics on the deal.Century Therapeutics (NASDAQ: IPSC) has announced a research collaboration and license agreement with Bristol Myers Squibb (NYSE: BMY) to…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
